They further found the resistance mechanisms to ALK TKIs mediated by both ALK and by a bypass signaling pathway mediated by EGFR, and these mechanisms can occur independently, or in the same cancer (Sasaki et al. 2011). The gene discussed is EGFR; the disease is cancer.